🇺🇸 FDA
Pipeline program

Lifileucel

IOV-END-201

Phase 2 mab active

Quick answer

Lifileucel for Endometrial Cancer is a Phase 2 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Endometrial Cancer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials